nicorette mentholmint 2 mg lääkepurukumi
mcneil / jntl consumer health (finland) oy - nicotine resinate - lääkepurukumi - 2 mg - nikotiini
nicorette mentholmint 4 mg lääkepurukumi
mcneil / jntl consumer health (finland) oy - nicotine resinate - lääkepurukumi - 4 mg - nikotiini
niquitin tropical 2 mg lääkepurukumi
perrigo sverige ab - nicotinum resin. - lääkepurukumi - 2 mg - nikotiini
niquitin tropical 4 mg lääkepurukumi
perrigo sverige ab - nicotinum resin. - lääkepurukumi - 4 mg - nikotiini
ebvallo
pierre fabre medicament - tabelecleucel - lymphoproliferative disorders - ebvallo is indicated as monotherapy for treatment of adult and paediatric patients 2 years of age and older with relapsed or refractory epstein-barr virus positive post-transplant lymphoproliferative disease (ebv+ ptld) who have received at least one prior therapy. for solid organ transplant patients, prior therapy includes chemotherapy unless chemotherapy is inappropriate.
nicorette 2 mg lääkepurukumi
mcneil / jntl consumer health (finland) oy - nicotine resinate - lääkepurukumi - 2 mg - nikotiini
nicorette 4 mg lääkepurukumi
mcneil / jntl consumer health (finland) oy - nicotine resinate - lääkepurukumi - 4 mg - nikotiini
tolerak 40 mg/g emulsiovoide
pierre fabre medicament - fluorouracil - emulsiovoide - 40 mg/g - fluorourasiili
recicort vet 1.77 mg/ml + 17.7 mg/ml korvatipat, liuos
le vet. beheer b.v. - salicylic acid, triamcinolone acetonide - korvatipat, liuos - 1.77 mg/ml + 17.7 mg/ml - triamsinoloni
dermanolon vet 1,77 mg/ml + 17,7 mg/ml sumute iholle, liuos
le vet. beheer b.v. - salicylic acid, triamcinolone acetonide - sumute iholle, liuos - 1,77 mg/ml + 17,7 mg/ml - triamsinoloni